Management Of Anterior Lenticonus In Alport's Syndrome
Published 2025 - 43rd Congress of the ESCRS
Reference: PP11.17 | Type: Free paper | DOI: 10.82333/tw3g-qx69
Authors: Shafi Balal* 1 , Marcello Leucci 1 , Nikolas Pontikos 2 , Daniel Gore 1 , Bruce Allan 1
1Moorfields Hospital,London,United Kingdom, 2University College London,London,United Kingdom
Purpose
To describe the management of anterior lenticonus in Alport's Syndrome
Setting
University public tertiary eye hospital
Methods
6 eyes of 3 consecutive patients with Alport's syndrome were included for analysis.
A full ophthalmological examination including corneal aberrometry, macular and
anterior segment OCT were performed before and after surgery in all patients.
Phacoaspiration was performed in all patients after a routine manual
capsulorhexis. IOL power calculation was performed using Barrett Universal
Formula II for all eyes. A monofocal IOL was implanted inside the capsular bag for
all patients.
Results
All of the included patients had already performed renal transplantation for chronic
renal failure. Clear lens extraction was uneventful in all patients. There was a
statistically significant improvement of both uncorrected and best-corrected visual
acuity in all patients. UCVA improved from LogMAR 1.46±0.24 to 0.21±0.10
p<0.001. BCVA improved from LogMAR 0.98±0.42 to 0.11±0.08 p<0.05.
Conclusions
Anterior lenticonus can be safely managed by clear lens extraction with IOL
implantation in eyes of patients with Alport's syndrome. Care should be taken
when performing anterior capsulorhexis due to the thinning of the anterior capsule
in this condition.